Search PubMed⌕ Search

Biomedical subjects

R A Martin

Publications and source records attributed to R A Martin.

At least 91 records · Page 5Linked to original sources

Office evaluation of dementia. How to arrive at a clear diagnosis and choose appropriate therapy.

About half of patients presenting with dementia have Alzheimer's disease, which cannot be prevented or reversed. Treatment of these patients is aimed at improving their quality of life and helping their families provide supportive care. About 15% of patients with dementia can be successfully treated. A detailed patient history, thorough physical examination, and appropriate laboratory testing are important to identify the treatable causes of dementia, such as normal-pressure hydrocephalus, Korsakoff's psychosis, and drug toxicity.

Aged↗

Sense of humor, hassles, and immunoglobulin A: evidence for a stress-moderating effect of humor.

This study was designed to investigate whether sense of humor moderates immunosuppressive effects of stress. At two time periods one and one-half months apart, forty subjects completed the Daily Hassles Scale and provided saliva samples for determining secretory immunoglobulin A (S-IgA) levels. Four scales were used to assess different aspects of the sense of humor. A negative correlation was obtained between frequency of hassles at time 1 and S-IgA levels at time 2 (r = -.32, p less than .05), suggesting an immunosuppressive effect of hassles. In support of our hypothesis, hierarchical multiple regression analyses revealed significant moderating effects of three of the four humor measures on this relationship between hassles and S-IgA. Subjects with low scores on the humor scales revealed a stronger negative relationship between hassles and S-IgA than did those with high humor scores. These results are discussed in terms of other research examining psychological influences on immune function.

Adult↗

Effects of dietary fatty acid saturation on serum and tissue cholesterol concentrations and fecal sterol excretion: a chronic metabolic study in the rat.

We studied the effect of the degree of fatty acid saturation on cholesterol metabolism in rats fed either a low cholesterol-low fat diet (control group), high cholesterol-low fat diet (Chol group), high cholesterol-high saturated fat diet (Chol-SF) or high cholesterol-high PUF diet (Chol-PUF). The highest serum cholesterol levels were found in the Chol-SF group. No significant difference in serum cholesterol was found between the Chol and Chol-PUF groups. The Chol-PUF group showed the greatest accumulation of cholesterol in the liver. There was no significant difference in fecal excretion of acidic sterols, cholesterol and coprostanol between the Chol-PUF and Chol-SF groups. We conclude that in chronic feeding experiments in rats: a) high dietary cholesterol intake results in hypercholesterolemia; b) the hypercholesterolemia is accentuated by high dietary SF but is unaffected by PUF; c) addition of PUF to high cholesterol diet leads to massive cholesterol accumulation in the liver which can partly account for the apparent hypocholesterolemic effect of PUF relative to SF; and d) differences in serum and tissue cholesterol levels between SF and PUF supplemented groups are unlikely to be due to their effects on fecal sterol excretion.

Animals↗

Preclinical toxicology of pirmenol hydrochloride.

Pirmenol hydrochloride (CI-845), a new orally effective antiarrhythmic agent, has undergone a comprehensive preclinical safety evaluation program. Repeated dose studies to evaluate chronic toxicity in rodents revealed few drug-related findings. A dose-related body weight gain suppression occurred in mice receiving up to 160 mg/kg for thirteen weeks. Rats also exhibited decreased body weight in a fifty-two-week study. Depressed fasting glucose levels were seen in rats at 50 mg/kg after thirteen weeks, but this effect was less prominent following fifty-two weeks of dosing. No other drug-related signs of toxicity were seen in rodents. Four-week repeated-dose intravenous studies in rats were uneventful. Occasional emesis and salivation, together with dryness of the oral mucosa, occurred in dogs given 10 mg/kg intravenously for four weeks. Drug-related increased heart rates, increased QRS duration, and reduced ST interval were seen thirty minutes postdose in dogs receiving 5 mg/kg or more intravenously. When dogs received pirmenol orally for fifty-two weeks, electrocardiographic and heart rate changes were variable and less pronounced than seen in the intravenous study. Clinical signs consisted of exaggerated pharmacologic responses similar to those found after intravenous dosing. Reproduction studies in rats and rabbits showed that pirmenol is not teratogenic. Reduced food intake and a 50% decrease in body weight gain were seen in rats at the top dose level of 150 mg/kg. Significantly reduced mean fetal weight and increased postimplantation loss indicated that 150 mg/kg was embryotoxic to rats. A top dose of 50 mg/kg in rabbits did not produce any signs of maternal or fetotoxicity, aside from a moderate suppression of maternal weight gain.(ABSTRACT TRUNCATED AT 250 WORDS)

Administration, Oral↗

Suspected chronic gastric volvulus in a dog with normal gastric emptying of liquids.

A 10-year-old German Shepherd Dog with intermittent eructation, borborygmi, flatulence, abdominal bloating, and vomiting was found to have gastric volvulus. Gastric emptying of liquids (determined with a modified emptying-time technique) was normal. Circumcostal gastropexy vastly reduced clinical signs and resulted in weight gain.

Animals↗

Management of peripheral neuropathy in diabetes mellitus. Recent research findings and their therapeutic implications.

Peripheral neuropathy in diabetes begins as a physiologic aberration related to hyperglycemia and its subsequent effects of endoneurial hypoxia, elevated sorbitol levels, and decreased myoinositol levels. Resultant decreases in sodium-potassium-adenosine triphosphatase levels ultimately lead to structural alterations at the nodes of Ranvier. Aldose reductase inhibitors and dietary myoinositol supplementation are being used in long-term clinical studies to monitor the possibility that they may prevent or reverse these abnormalities. In the meantime, symptomatic treatment remains the mainstay of management.

Autonomic Nervous System Diseases↗

Preclinical toxicology of pirmenol hydrochloride.

Pirmenol hydrochloride, a novel pyridinemethanol derivative, is a long-acting class Ia antiarrhythmic agent. Preclinical toxicology data were obtained in rat, mouse, dog and rabbit. In acute toxicity studies by oral and intravenous routes, no pathologic changes were observed in surviving mice, rats and dogs. In repeated dose toxicity studies, no drug-related pathologic changes were evident; dryness of the oral mucosa in dogs and body weight gain reductions in rodents were the only significant clinical signs. In a chronic (52 week) toxicity study in rats, pirmenol given in the diet was tolerated clinically at doses up to 100 mg/kg/day. No drug-related aberrations in clinical laboratory parameters or ophthalmic or pathologic findings were evident. In a similar study in beagle dogs, pirmenol was tolerated clinically at a dosage up to 30 mg/kg/day. No significant changes in biochemical, hematologic, urinary or bone marrow determinations were found in either species. In reproductive toxicology studies in rats, pirmenol had no significant effect on litter size or embryonic viability. In rabbits pirmenol had no effect on average litter size, embryonic viability or fetal wastage. Given to male rats, pirmenol had no overt effects on fertility. Pirmenol failed to elicit deoxyribonucleic acid damage or induce cytogenetic alterations. Pirmenol appears to be without significant limiting toxicologic properties.

Administration, Oral↗

High-performance liquid chromatographic determination of the mycotoxins patulin, penicillic acid, zearalenone and sterigmatocystin in artificially contaminated cocoa beans.

A high-performance liquid chromatographic (HPLC) method has been developed to allow the determination of patulin, penicillic acid, sterigmatocystin and zearalenone in samples of cocoa beans. When this method is combined with a method that was reported earlier for the determination of ochratoxin A [W. J. Hurst and R. A. Martin, Jr., J. Chromatogr., 265 (1983) 353], it allows for the determination of five mycotoxins. Samples were extracted with an acidic acetonitrile solution, partitioned with hexane to remove fat interferences and then partitioned with chloroform to remove the toxin containing fraction. Interferences were removed by the use of a bonded phase column followed by the final HPLC determination step, which uses a cyano column with a hexane-1-propanol-acetic acid mobile phase with dual channel UV detection at 245 and 280 nm. The method exhibits good linearity, accuracy and precision.

Cacao↗

Chocolate.

Explore the source record for details and available documents.

Cacao↗

Left hepatic vein attenuation for treatment of patent ductus venosus in a dog.

Patent ductus venosus was identified in a young dog. Surgical attenuation of the anomalous vessel was performed by partial ligation of the left hepatic vein. Clinical signs resolved after surgery, and laboratory values returned to normal. Jejunal venous portography, performed 8 weeks after surgery, revealed complete occlusion of the patent ductus venosus, with normal portal vasculature to the right and central divisions of the liver. Atrophy of the left hepatic division resulted.

Animals↗

Treatment of cryptococcosis in three cats, using ketoconazole.

Ketoconazole was effective in the treatment of cryptococcosis in 3 cats. A dosage of 10 to 15 mg/kg of body weight was given once or twice daily with a meal for 11 to 33 weeks. Fungal cultures and serotesting were used to assess the efficacy of treatment and resolution of active infection. In some of the cats, the treatment was associated with gastrointestinal signs and increased serum liver enzyme activity. Ketoconazole has been used in human beings, dogs, and cats for the treatment of systemic mycoses.

Animals↗

Evaluation of chronic toxicity and carcinogenesis in rodents with the synthetic analgesic, tilidine fumarate.

The carcinogenic potential of tilidine fumarate, a synthetic analgesic, was studied for 80 and 104 weeks in mice and rats, respectively. Groups of 50 albino CF1 mice and 65 albino Wistar rats of each sex received tilidine fumarate-lactose blend (1:1) at doses of 100, 40 and 16 mg/kg. The control groups consisted of 100 mice and 115 rats of each sex and received the lactose vehicle only. Treatment-related non-neoplastic changes consisted of reversible, increased cytoplasmic eosinophilia of hepatocytes in high and mid dose rats corresponding to areas of proliferating smooth endoplasmic reticulum; and an increased incidence in high dose rats of proliferative or cystic lesions of the biliary epithelium. Adequate survival rates allowed stringent statistical analysis of neoplasia. Tilidine did not evoke increased tumor incidences or changes in the average latency or onset of tumors in either species. The most frequent tumors represented spontaneous neoplasia characteristic of historical background incidence in these strains. In mice, the only statistically significant (P less than 0.01) variation in tumor incidence was an increased rate of lung alveologenic adenocarcinomas in females at 100 mg/kg (24%), compared with the concurrent untreated controls (10%), but without a statistically significant difference from historical control data (27%). Female rats given 100 mg/kg showed statistically significant (P less than 0.01) decreased incidences of mammary fibroadenoma and pituitary adenoma. From these data, it was concluded that the synthetic analgesic tilidine does not possess tumorigenic potential in rodents.

Administration, Oral↗

Body composition of lactating and dry Holstein cows estimated by deuterium dilution.

In three experiments patterns of water turnover and body composition estimated by deuterium oxide were studied in Holstein cows. In the first experiment, four lactating cows were infused with deuterium oxide, and blood samples were taken during 4-d collection. Milking was stopped; cows were reinfused with deuterium oxide and resampled. Slopes of deuterium oxide dilution curves indicated lactating cows turned water over more rapidly than nonlactating cows. In the second experiment with the same four cows, during 4-d collection, deuterium oxide concentrations in milk, urine, and feces showed dilution patterns similar to deuterium oxide in blood. Sampling milk may be an alternative to sampling blood. In the third experiment, 36 Holstein cows were fed 55, 65, or 75% alfalfa, smooth bromegrass, or equal parts of each forage as total mixed rations; remaining portions of rations were a grain mixture. Body composition was estimated at -1, 1, 2, 3, 4, and 5 mo postpartum. Empty body water, protein, mineral, fat, and fat percentage decreased from prepartum to postpartum. First calf heifers contained less empty body water, protein, and mineral than older cows. Cows fed diets with 55% forage had more body fat than those fed diets with 75% forage. Cows fed alfalfa-based diets had more gastrointestinal fill regardless of grain than cows fed diets that contained alfalfa and smooth bromegrass. Gastrointestinal fill of cows increased from prepartum to 5 mo postpartum.

Animals↗